TELA Bio (TELA) Accumulated Expenses (2018 - 2026)

TELA Bio has reported Accumulated Expenses for 9 years, with the latest figure at $15.3 million in Q2 2026.

• On a quarterly basis, Accumulated Expenses rose 9.64% year-over-year to $15.3 million in Q2 2026; TTM through Jun 2026 was $15.3 million, a 9.64% increase from a year earlier, with the FY2025 full-year figure at $15.7 million, up 16.47% from the prior year.
• Accumulated Expenses was $15.3 million for Q2 2026 at TELA Bio, up from $13.9 million in the prior quarter.
• The five-year high for Accumulated Expenses was $15.7 million in Q4 2025, with the low at $6.6 million in Q1 2022.
• Average Accumulated Expenses over 5 years is $12.4 million, with a median of $12.6 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2024: Accumulated Expenses soared 60.88% in 2022, then dropped 12.08% in 2024.
• Over 5 years, Accumulated Expenses stood at $10.9 million in 2022, then surged by 40.77% to $15.3 million in 2023, then dropped by 12.08% to $13.5 million in 2024, then advanced by 16.47% to $15.7 million in 2025, then fell by 2.11% to $15.3 million in 2026.
• The last three Accumulated Expenses figures came in at $15.3 million (Q2 2026), $13.9 million (Q1 2026), and $15.7 million (Q4 2025), per Business Quant data.